(Q43032783)

12 November 2017

Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

5

1 reference

12 November 2017

8

Alter HJ

1 reference

12 November 2017

6

Shih JW

1 reference

12 November 2017

Yeo AE

1

1 reference

12 November 2017

Ghany M

2

1 reference

12 November 2017

Conry-Cantilena C

3

1 reference

12 November 2017

Melpolder JC

4

1 reference

12 November 2017

Hoofnagle JH

7

1 reference

12 November 2017

1 July 2001

1 reference

Journal of Viral Hepatitis

12 November 2017

1 reference

12 November 2017

8

1 reference

12 November 2017

4

1 reference

12 November 2017

256-263

1 reference

Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease

12 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Serial quantitative analysis of serum hepatitis C virus RNA level in patients with acute and chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Quantitation of hepatitis C virus RNA by competitive polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Infection of peripheral mononuclear blood cells by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Hepatitis C virus: quantitation and distribution in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Serum HCV RNA levels assessed by quantitative NASBA: stability of viral load over time, and lack of correlation with liver disease. The Trent HCV Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Sequential serum hepatitis C viral RNA levels longitudinally assessed by branched DNA signal amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

HCV RNA levels in serum, liver, and peripheral blood mononuclear cells of chronic hepatitis C patients and their relationship to liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Role of the specific T-cell response for clearance and control of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Cellular immune response to the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Virus-host interaction in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Hepatitis C virus genotypes are not responsible for development of serious liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Clinical backgrounds of the patients having different types of hepatitis C virus genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00302.X

Quantitation of hepatitis C virus genome molecules in plasma samples

21 January 2018

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1365-2893.2001.00302.X

Correlation of HCV-RNA levels in serum and liver of patients with chronic hepatitis C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1365-2893.2001.00302.X

Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1365-2893.2001.00302.X

Severity of liver disease with different hepatitis C viral clones

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1365-2893.2001.00302.X

Identifiers

DOI

10.1046/J.1365-2893.2001.00302.X

1 reference

12 November 2017

1 reference